Effect of Inactivated COVID-19 Vaccine, Sinovac on Survival in Intensive Care Unit
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 96
- 试验地点
- 1
- 主要终点
- survival data
研究概览
简要总结
Effect of Inactivated COVID-19 Vaccine (Sinovac) on survival in intensive care unit, Single Center Experience
详细描述
Turkey has started vaccinate healthcare professionals at 13 January 2021 by Sinovac vaccine and declared a step by step inclusion schedule The primary aim of the study is to compare clinical, laboratory and survival data of COVID-19 patients who were vaccinated at least 14 days before enrollment to the study with COVID-19 patients not vaccinated although they would have. The secondary aim is to compare age of enrolled patients to ICU due to SARS-CoV-2 infection with patients admitted to ICU before start of vaccination program.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 65 Years 至 —（Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with covid 19 over the age of 65 who were admitted to the intensive care unit between 1 April 2021 and 15 May 2021
排除标准
- •admissions to ICU due to reasons other than COVID-19, age younger than 65, continued admission at the end of enrolment date,
结局指标
主要结局
survival data
时间窗: 30 days
If the patient dies, we have reached an outcome
次要结局
未报告次要终点
研究者
Sultan Acar Sevinç
consultant doctor
Sisli Hamidiye Etfal Training and Research Hospital